264 related articles for article (PubMed ID: 2005075)
21. [Double-blind comparative study of alprazolam (Xanax) and amitriptyline in the treatment of anxiety associated with depression].
Bernardi F; Cairoli S; D'Aurizio C; De Rosa A; Grasso A; Sannino V; Savoldi F; Sorge F; Casadei GL
Minerva Psichiatr; 1988; 29(4):203-10. PubMed ID: 3074234
[No Abstract] [Full Text] [Related]
22. Comparison of alprazolam and imipramine for treatment of outpatient depression.
Overall JE; Biggs J; Jacobs M; Holden K
J Clin Psychiatry; 1987 Jan; 48(1):15-9. PubMed ID: 3542981
[TBL] [Abstract][Full Text] [Related]
23. Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
Rosenberg R; Bech P; Mellergård M; Ottosson JO
Acta Psychiatr Scand Suppl; 1991; 365():46-52. PubMed ID: 1862734
[TBL] [Abstract][Full Text] [Related]
24. Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients.
Mendels J; Schless AP
J Clin Psychiatry; 1986 Jul; 47(7):357-61. PubMed ID: 2873131
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
Taylor CB; Hayward C; King R; Ehlers A; Margraf J; Maddock R; Clark D; Roth WT; Agras WS
J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
[TBL] [Abstract][Full Text] [Related]
26. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
Lesser IM; Rubin RT; Pecknold JC; Rifkin A; Swinson RP; Lydiard RB; Burrows GD; Noyes R; DuPont RL
Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
[TBL] [Abstract][Full Text] [Related]
27. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder.
Lydiard RB; Laraia MT; Ballenger JC; Howell EF
Am J Psychiatry; 1987 May; 144(5):664-5. PubMed ID: 3578580
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of placebo response during long-term treatment of panic disorder.
Dager SR; Khan A; Cowley D; Avery DH; Elder J; Roy-Byrne P; Dunner DL
Psychopharmacol Bull; 1990; 26(3):273-8. PubMed ID: 2274625
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
Hoehn-Saric R; McLeod DR; Zimmerli WD
J Clin Psychiatry; 1988 Aug; 49(8):293-301. PubMed ID: 3045099
[TBL] [Abstract][Full Text] [Related]
30. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
Maier W; Rosenberg R; Argyle N; Buller R; Roth M; Brandon S; Benkert O
Eur Arch Psychiatry Clin Neurosci; 1991; 241(1):22-30. PubMed ID: 1832302
[TBL] [Abstract][Full Text] [Related]
31. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
Brady KT; Clary CM
Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
[TBL] [Abstract][Full Text] [Related]
32. Pharmacotherapeutic treatment of panic disorder in patients presenting with chest pain.
Beitman BD; Basha IM; Trombka LH; Jayaratna MA; Russell B; Flaker G; Anderson S
J Fam Pract; 1989 Feb; 28(2):177-80. PubMed ID: 2644392
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder.
Pollack MH; Otto MW; Tesar GE; Cohen LS; Meltzer-Brody S; Rosenbaum JF
J Clin Psychopharmacol; 1993 Aug; 13(4):257-63. PubMed ID: 8376613
[TBL] [Abstract][Full Text] [Related]
34. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
[TBL] [Abstract][Full Text] [Related]
35. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
Schweizer E; Rickels K; Weiss S; Zavodnick S
Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
[TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up of chronic depression treated with imipramine.
Kocsis JH; Sutton BM; Frances AJ
J Clin Psychiatry; 1991 Feb; 52(2):56-9. PubMed ID: 1993636
[TBL] [Abstract][Full Text] [Related]
37. The drug treatment of panic disorder.
Matuzas W; Jack E
Psychiatr Med; 1991; 9(2):215-43. PubMed ID: 1677479
[TBL] [Abstract][Full Text] [Related]
38. The effect of long-term imipramine treatment on carbon dioxide-induced anxiety in panic disorder patients.
Woods SW; Charney DS; Delgado PL; Heninger GR
J Clin Psychiatry; 1990 Dec; 51(12):505-7. PubMed ID: 2175307
[TBL] [Abstract][Full Text] [Related]
39. Growing placebo response rate: the problem in recent therapeutic trials?
Uhlenhuth EH; Matuzas W; Warner TD; Thompson PM
Psychopharmacol Bull; 1997; 33(1):31-9. PubMed ID: 9133749
[TBL] [Abstract][Full Text] [Related]
40. Implications of restrictive diagnosis for compliance to antidepressant drug therapy: alprazolam versus imipramine.
Overall JE; Donachie ND; Faillace LA
J Clin Psychiatry; 1987 Feb; 48(2):51-4. PubMed ID: 3542984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
